跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack
Approved
STANDARD
ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack
Generic Health Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
398714af4966b155
Company
Generic Health Pty Ltd
Type
Standard
Approval Details
Approval Id
398714af4966b155
Product Name
ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack
Artg Id
370795
Artg Name
ATOVAQUOPRO GH 62.5/25 atovaquone/proguanil hydrochloride 62.5/25 mg film-coated tablet blister pack
Sponsor
Generic Health Pty Ltd
Company Detail Path
/organization/generic-health-pty-ltd
Artg Date
2022-08-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
398714af4966b155
Type
Standard
Back to TGA Approvals